The big opportunities within supplements in 2023 and beyond will be within prediabetes, brain health, fermentates, and bacterial phages, according to predictions from white label supplements firm PharmaLinea.
The HMO opportunity, synbiotic mechanisms of action, phages, personalisation, and the gut-brain axis are just some of the topics to be explored at the 2023 event in Barcelona, Spain.
A combination of bacteriophages (phages) may precisely target and suppress gut bacteria associated with inflammatory bowel diseases (IBD), says a new study from Israel that shows the potential of this emerging class of microbiome modulators.